Miltenyi Biotec India Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
- Paid Up Capital ₹ 2.51 M
- Company Age 1 Year 3 Months
- Last Filing with ROC 31 Mar 2024
About Miltenyi Biotec India
Miltenyi Biotec India Private Limited (MBIPL) is a Private Limited Indian Non-Government Company incorporated in India on 20 November 2023 (One year and three months 5 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 2.51 M, as per Ministry of Corporate Affairs (MCA) records.
Antoon Overstijns, Norbert Hentschel, Stefan Miltenyi, and Two other members serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U32509TS2023PTC179183
- Company No.
179183
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Nov 2023
- Date of AGM
22 Nov 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Who are the key members and board of directors at Miltenyi Biotec India?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Priya Hingorani | Managing Director | 22-Nov-2024 | Current |
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Antoon Overstijns  | Director | 29-Mar-2024 | Current |
| Norbert Hentschel | Director | 29-Mar-2024 | Current |
| Stefan Miltenyi | Director | 29-Mar-2024 | Current |
| Boris Stoffel | Director | 29-Mar-2024 | Current |
Financial Performance of Miltenyi Biotec India.
Enhance accessibility to Miltenyi Biotec India's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Miltenyi Biotec India?
Unlock access to Miltenyi Biotec India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Miltenyi Biotec India?
Unlock and access historical data on people associated with Miltenyi Biotec India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Miltenyi Biotec India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Miltenyi Biotec India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
